Drug application
POTASSIUM CHLORIDE 20MEQ IN DEXTROSE 5% AND LACTATED RINGER'S IN PLASTIC CONTAINER (CALCIUM CHLORIDE, DEXTROSE, POTASSIUM CHLORIDE and 2 more)
Drugs@FDA ANDA 211428 · FRESENIUS KABI USA
Key facts
| Drug name | POTASSIUM CHLORIDE 20MEQ IN DEXTROSE 5% AND LACTATED RINGER'S IN PLASTIC CONTAINER |
|---|---|
| Active ingredients | CALCIUM CHLORIDE, DEXTROSE, POTASSIUM CHLORIDE, SODIUM CHLORIDE, SODIUM LACTATE |
| Application type | ANDA |
| Application number | 211428 |
| Company | FRESENIUS KABI USA |
| Dosage forms | INJECTABLE, INJECTION |
| Strength | 20MG/100ML;5GM/100ML;179MG/100ML;600MG/100ML;310MG/100ML |
| Marketing status | Discontinued |
| Reference listed drug | No |
| Latest submission status date | Nov 9, 2021 |
At a glance
- 1–9 Submissions
- None Label versions
- 1–9 Products
- None Therapeutic equivalents
- Yes FDA letters on file
- No FDA reviews on file
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Drugs@FDA applications
Drugs@FDA covers FDA-approved brand-name and generic drugs and therapeutic biologics, with their applications (NDA, ANDA or BLA), products, submissions and labels.
Source: U.S. Food and Drug Administration (FDA), Drugs@FDA · Source date: